We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Test Seizure Treatments on Children as Young as Two, FDA Guidance Advises
Test Seizure Treatments on Children as Young as Two, FDA Guidance Advises
Sponsors of drugs to treat partial onset seizures (POS) in pediatric patients should extend their trials to children as young as two, according to a final guidance the FDA released on Thursday.